Jiangsu, China

Chiung-Wen Tsai

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Chiung-Wen Tsai in Neutron Capture Therapy

Introduction

Chiung-Wen Tsai is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medical technology, particularly in neutron capture therapy systems. His innovative work has led to the development of advanced systems that enhance the effectiveness of cancer treatments.

Latest Patents

Chiung-Wen Tsai holds two patents related to neutron capture therapy systems. His latest patents describe a neutron capture therapy system that comprises a beam shaping assembly configured to shape a neutron beam. This system includes an accelerator for generating a charged particle beam and a neutron generator for producing a neutron beam after irradiation by the charged particle beam. The beam shaping assembly features a moderator and a reflecting assembly that surrounds the moderator. The reflecting assembly is designed to deflect neutrons back to the neutron beam, utilizing a lead-antimony alloy to improve structural strength and mitigate creep effects.

Career Highlights

Chiung-Wen Tsai is currently associated with Neuboron Medtech Ltd., where he continues to innovate in the field of medical technology. His work focuses on enhancing the capabilities of neutron capture therapy, which is crucial for improving cancer treatment outcomes.

Collaborations

Chiung-Wen Tsai collaborates with several talented individuals, including Weilin Chen and Ming-Chen Hsiao. Their combined expertise contributes to the advancement of their projects and the development of innovative solutions in medical technology.

Conclusion

Chiung-Wen Tsai's contributions to neutron capture therapy systems exemplify the impact of innovation in medical technology. His patents and ongoing work at Neuboron Medtech Ltd. highlight the importance of advancements in cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…